‘India not to stop hydroxychloroquine treatment in mild cases'

​​HCQ, currently used to treat lupus and rheumatoid arthritis, has split world opinion on its use in Covid-19 management, even as India said the decision was “taken based on risk-benefit assessment.”

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Y5vCcK
via IFTTT